Skip to main content
Deutsch

Search

  1. Home
  2. Search

Webseiten-Inhalte

Jan Pencik erhält Max-Kade-Stipendium der Österreichischen Akademie der Wissenschaften ... 2010 am LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Wien bei Lukas Kenner seine Doktorarbeit begann. Nach dem Abschluss seines PhD-Studiums arbeitete er als PostDoc in der Arbeitsgruppe von Lukas Kenner am Klinischen Institut für Pathologie der MedUni Wien und am Center for Biomarker... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-jaenner-2019/jan-pencik-erhaelt-max-kade-stipendium-der-oesterreichischen-akademie-der-wissenschaften/?L=3
Jan Pencik erhält Max-Kade-Stipendium der Österreichischen Akademie der Wissenschaften ... 2010 am LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Wien bei Lukas Kenner seine Doktorarbeit begann. Nach dem Abschluss seines PhD-Studiums arbeitete er als PostDoc in der Arbeitsgruppe von Lukas Kenner am Klinischen Institut für Pathologie der MedUni Wien und am Center for Biomarker... https://www.meduniwien.ac.at/web/index.php?id=4448&L=3&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=4&cHash=210d26d93fcbc87bd2679fe7536cc56f
Jan Pencik erhält Max-Kade-Stipendium der Österreichischen Akademie der Wissenschaften ... 2010 am LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Wien bei Lukas Kenner seine Doktorarbeit begann. Nach dem Abschluss seines PhD-Studiums arbeitete er als PostDoc in der Arbeitsgruppe von Lukas Kenner am Klinischen Institut für Pathologie der MedUni Wien und am Center for Biomarker... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-jaenner-2019/jan-pencik-erhaelt-max-kade-stipendium-der-oesterreichischen-akademie-der-wissenschaften/menschen-der-meduni-wien/?L=3
Detailsite | MedUni Vienna ... Lukas Kenner for the Clinical Institute of Pathology at MedUni Vienna. Scientists believe that in conventional chemotherapy, cancer cells which spread through the body are destroyed, but not the original “cancer stem cells” by which the tumour is produced. As Lukas Kenner, Director of the Institute of... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=3219&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=3b4d0528c57007cdb6cdc9967ba6eea2
Detailsite | MedUni Vienna ..., infertility and secondary cancers. Up to 40 percent of children diagnosed with ALCL also suffer a relapse, which requires additional chemotherapy.“The origins of ALCL could be traced to a gene disorder in the development of blood-producing stem cells, which are located in the thymus,” explains Lukas Kenner for the Clinical Institute of Pathology at MedUni Vienna. Scientists believe that in conventional chemotherapy, cancer cells which spread through the body are destroyed, but not the original “cancer stem cells” by which the tumour is produced. As Lukas Kenner, Director of the Institute of Laboratory... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/cause-of-an-aggressive-form-of-childhood-cancer-identified/?L=3
Jan Pencik awarded Max Kade Grant from the Austrian Academy of Sciences ...Jan Pencik studied biochemistry in Olomouc and Brno (Czech Republic) from 2005 to 2009. He spent his research placement at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Vienna in 2010. After completing his PhD, he worked as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed) in Graz. Since the beginning of 2019, Pencik has been a Research Fellow at Salk Institute for Biological Studies in San Diego (USA... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/jan-pencik-awarded-max-kade-grant-from-the-austrian-academy-of-sciences/?cHash=b6880a0106e790a7bc7e97aaa8e340b4&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13
Jan Pencik awarded Max Kade Grant from the Austrian Academy of Sciences ...Jan Pencik studied biochemistry in Olomouc and Brno (Czech Republic) from 2005 to 2009. He spent his research placement at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR (Ludwig Boltzmann Institute for Cancer Research) in Vienna in 2010. After completing his PhD, he worked as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed) in Graz. Since the beginning of 2019, Pencik has been a Research Fellow at Salk Institute for Biological Studies in San Diego (USA... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/jan-pencik-awarded-max-kade-grant-from-the-austrian-academy-of-sciences/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13&cHash=b6880a0106e790a7bc7e97aaa8e340b4
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/forschung/researcher-profiles/researcher-profiles/detail/?res=david_haberl&cHash=18a63344c3501f07553b3b317989c277
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/en/research/researcher-profiles/researcher-profiles/index.php?id=688&res=david_haberl
Researcher of the MedUni Vienna ...Dipl.-Ing. David Haberl, PhD Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Research Associate (Postdoc) ORCID: 0000-0003-2050-097X david.haberl@meduniwien.ac.at Keywords Artificial Intelligence; Biomedical Research; Molecular Imaging; Monte Carlo Method; Pattern Recognition, Automated; Positron-Emission Tomography Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Computational Nuclear Medicine... https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?res=david_haberl&cHash=18a63344c3501f07553b3b317989c277